-

KARL STORZ Launches CollaboratOR 3D for Apple Vision Pro

Powerful new technology further extends possibilities for education and collaboration in the surgical suite.

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Pioneering MedTech company KARL STORZ is proud to announce the release of the CollaboratOR 3D app for Apple Vision Pro. Designed in concert with innovative software developer T1V, the CollaboratOR 3D app complements the functionality of the integrated operating room solution known as OR1.

KARL STORZ has a longstanding commitment to training and educating healthcare professionals to help them take full advantage of emerging medical technologies. Working closely with healthcare providers, the company identified a need to improve the educational experience and collaboration opportunities for new surgical residents as well as practicing surgeons across a wide range of specialties. With the CollaboratOR 3D app for Apple Vision Pro, surgical staff can immerse themselves in 3D content from surgical procedures—without even entering the operating room. This provides residents and surgeons with enhanced learning opportunities while allowing teams to scale their training efforts.

The CollaboratOR 3D app serves as an extension of the CollaboratOR, an interactive ecosystem for the OR1 integrated operating room. The app leverages Apple Vision Pro’s ability to seamlessly blend digital content with the physical world, allowing for closer coordination, communication, and education among the surgical team, wherever they may be. While not intended for use by the surgeon during surgery, CollaboratOR is designed to take full advantage of the breakthrough display, which offers exceptional 3D/4K surgical video quality provided by KARL STORZ endoscopy systems.

“KARL STORZ has built a reputation for exceptional surgical visualization and integration technologies,” says Christy Gaudet, VP of Surgical Sales & Marketing at KARL STORZ United States. “CollaboratOR is designed to boost efficiency in the operating room while empowering greater collaboration for the entire surgical staff, from any location, for any surgical specialty. The new CollaboratOR 3D app for Apple Vision Pro, developed with our partners at T1V, takes this to the next level, with a clear focus on the needs of healthcare providers and their patients.”

“We will continue to work with T1V to explore the future of medical education and collaboration in the OR,” says Connie Padden, Director of OR1 Technology Integration at KARL STORZ United States. “The release of the CollaboratOR 3D app for Apple Vision Pro aligns with our long-term vision to apply tomorrow’s technology to today’s most pressing healthcare needs. Harnessing the power of fully immersive spatial computing further advances our mission of enabling anywhere care.”

The CollaboratOR 3D app is available for free download on the App Store.

About KARL STORZ

KARL STORZ is an innovative leader in endoscopic technology and surgical imaging solutions across virtually all surgical specialties. Its integrated operating room solutions enhance collaboration to improve clinical efficiency and outcomes inside the hospital and other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit www.karlstorz.com.

About T1V

With 19 patents in visual collaboration software, T1V is a leading innovator in large-scale, interactive software technology. The company’s software ecosystem supports total interoperability with the many devices, programs, and platforms of today’s hybrid meeting and learning spaces—enabling users to truly collaborate anytime, anywhere. To learn more, visit www.t1v.com.

Contacts

Susan Mancia
Marketing Communications
KARL STORZ United States
(562) 841-1515

KARL STORZ


Release Versions

Contacts

Susan Mancia
Marketing Communications
KARL STORZ United States
(562) 841-1515

Social Media Profiles
More News From KARL STORZ

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +. ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms. Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparos...

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...
Back to Newsroom